Risco de úlcera nos pés e infusão contínua de insulina: avaliação em portadores de DM1

Abstract

Objectives: To identify the risk of ulcer in individuals with DM1 in use of continuous subcutaneous insulin infusion in the Federal District, Brazil. Methods: A descriptive cross-sectional study with 18 patients with continuous subcutaneous insulin infusion in the Distrito Federal, enrolled in the Secretary of Health of Distrito Federal Diabetes Program, a study carried out in the Specialized Center for Diabetes, Obesity and Hypertension of Secretary of Health of Distrito Federal, between September 2017 and February 2018. Results: No patient presented diabetic polyneurophaty or peripheral artery disease, only 5 (27,7%) presented neuropathic pain. The loss of protective sensation was absent in 20 (100%) of the individuals, the most common clinical findings during foot inspection were the presence of callosity 12 (66,6%) and presence of dry skin 14 (77,7%). Conclusions: 18 (100%) of the study population was classified as 0 risk for the development of the foot ulcer, which reveals the importance of continuous subcutaneous insulin infusion as a facilitator in diabetes control, preventing chronic complications and especially the development of ulcers on feet.